期刊文献+

不同性别患者预注顺阿曲库铵加快起效的半数有效剂量 被引量:4

Median effective dose of cisatracurium priming accelerating onset of neuromuscular block in patients of different genders
原文传递
导出
摘要 目的 探讨不同性别患者预注顺阿曲库铵加快起效的半数有效剂量(ED50).方法 择期拟在全身麻醉下行腹部手术的患者90例,年龄18~55岁,分为2组(n=45):男性组(M组)和女性组(F组).采用TOF-Watch SX型加速度肌松监测仪对尺神经行单次颤搐刺激,监测拇内收肌肌颤搐情况.静脉注射咪达唑仑0.04 mg/kg、芬太尼1 μg/kg,患者意识消失后开启加速度肌松监测仪,静脉注射顺阿曲库铵预注剂量,3 min后静脉注射芬太尼5 μg/kg、异丙酚2 mg/kg,静脉注射预注量后4 min,静脉注射顺阿曲库铵剩余插管剂量(3×ED95即0.15 mg/kg减去预注量),当单刺激颤搐值与对照值的比值下降至10%,行气管插管.静脉输注异丙酚、瑞芬太尼,吸入异氟烷维持麻醉.预注量根据序贯法确定,预注量从5μg/kg(10%ED95)开始,各相邻剂量比值为1.2.记录给予预注量后4min时单刺激颤搐值与对照值的比值、90%起效时间、起效时间、最大阻滞程度、临床作用时间.计算预注顺阿曲库铵加快起效的ED50及其95%可信区间(CI).结果 M组90%起效时间长于F组(P<0.05),其余肌松效应指标两组比较差异无统计学意义(P>0.05).预注顺阿曲库铵加快起效的ED50:男性为21.36μg/kg,95%CI为20.52~22.23μg/kg;女性为14.53 μg/kg,95%CI为13.77~15.33μg/kg,男性高于女性(P<0.05).结论 预注顺阿曲库铵加快起效的ED50:男性为21.36μg/kg,女性为14.53 μg/kg,男性高于女性. Objective To investigate the median effective dose (ED50) of cisatracurium priming accelerating the onset of neuromuscular block in patients of different genders. Methods Ninety ASA Ⅰ or Ⅱ patients aged 18-55 yr undergoing elective abdominal operation under general anesthesia were divided into 2 groups ( n = 45 each): male group (group M) and female group (group F). Neuromuscular block was monitored with accelerograph F (TOF-Watch SX). A single twitch stimulation of ulnar nerve was used to monitor neuromuscular function.Anesthesia was induced with midazolam 0.04 mg/kg and fentanyl 1 μg/kg. Accelerograph F was opened after the patients lost consciousness. The priming dose of cisatracurium was injected intravenously, then fentanyl 5 μg/kg and propofol 2 mg/kg were injected intravenously 3 min later and the left dose of cisatracurium for intubation was injected intravenously 4 min later. Tracheal intubation was performed when the ratio of the single twitch stimulation value to control value (T/Tc). decreased to 10%. Anesthesia was maintained with iv infusion of propofol and remifentanil and inhalation of isoflurane. The priming dose of cisatracurium was determined by up-and-down sequential trial. The initial priming dose was set at 5 μg/kg. The ratio of two successive doses was 1.2. T/Tc, time to 90% block, onset time, maximal neuromuscular block and clinical duration were recorded 4 min after the administration of the priming dose. The ED50 and 95% confidence interval (CI) of cisatracurium priming required to accelerate the onset were caculated. Results Time to 90% block was significantly longer-in group M than in group F (P <0.05). No significant difference was found in the other parameters among the groups. The ED50 and 95% CI of cisatracurium priming required to accelerate the onset were 21.36 μg/kg (95% CI 20.52-22.23 μg/kg)in group M and 14.53 μg/kg (95% CI 13.77-15.33 μg/kg) in group F. The ED50 was significantly higher in group M than in group F ( P < 0.05). Conclusion The ED50 of cisatracurium priming accelerating thd onset is 21.36 and 14.53 μg/kg in male and female respectively and it is significantly higher in male than in female.
出处 《中华麻醉学杂志》 CAS CSCD 北大核心 2010年第8期900-903,共4页 Chinese Journal of Anesthesiology
关键词 阿曲库铵 性别因素 剂量效应关系 药物 Atracurium Sex factrs Dose-response relationship,drug
  • 相关文献

参考文献12

  • 1庄心良,曾因明,陈伯銮.现代麻醉学.3版,北京:人民卫生出版社,2004:514-534
  • 2Bergeron L,Bevan DR,Berrill A,et al.Concentration-effect relationship of cisatracurium at three different dose levers in the anesthetized patient.Anethesiology,2001,95(2):314-323.
  • 3Schmidt J,Irouschek A,Muenster T,et al.A priming technique accelerates onset of neuromuscular blockade at the laryngeal adductor muscles.Can J Anaesth,2005,52(1):50-54.
  • 4Pühringer FK,Scheller A,Kleinsasser A,et al.The effect of different priming doses on the pharmacodynamics of cisatracurium.Anaesthesist,2000,49(2):102-105.
  • 5Xue FS,Tong SY,Liao X,et al.Dose-response and time course of effect of rocuronium in male and female anesthetized patients.Anesth Analg,1997,85(3):667-671.
  • 6Semple P,Hope DA,Clybum P,et al.Relative potency of vecuronium in male and female patients in Britain and Australia.Br J Anaesth,1994,72(2):190-194.
  • 7Lund I,Stovner J.Dose-Response curves for tubocurarine,alcuronium and pancuronium.Acta Anaesthesiol Scand Suppl,1969,37:238-242.
  • 8Deepika K,Kenaan CA,Bikhazi GB,et al.Influence of the priming technique on pharmacodynamics and intubating conditions of cisatracurium.J Clin Anesth,1999,11(7):572-575.
  • 9Debaene B,Lieutaud T,Billard V,et al.ORG 9487 neuromuscular block at the adductor pollicis and the laryngeal adductor muscles in humans.Anesthesiology,1997,86(6):1300-1305.
  • 10Paton WD,Waud DR.The margin of safety of neuromuscula transmission.J Physiol,1967,191:59-90.

共引文献9

同被引文献30

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部